Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators
Authors
Keywords
-
Journal
Frontiers in Chemistry
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-09
DOI
10.3389/fchem.2021.671483
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New perspectives in oral peptide delivery
- (2021) Alessandra T. Zizzari et al. DRUG DISCOVERY TODAY
- Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
- (2021) Lauren M. Slosky et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in Mice
- (2021) Todd M. Hillhouse et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Antagonism of the mu-delta opioid receptor heterodimer enhances opioid antinociception by activating Src and calcium/calmodulin-dependent protein kinase II signaling
- (2021) Attila Keresztes et al. PAIN
- A membrane-tethering pepducin derived from formyl peptide receptor 3 shows strong therapeutic effects against sepsis
- (2020) Ha Young Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ProtCID: a data resource for structural information on protein interactions
- (2020) Qifang Xu et al. Nature Communications
- Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery
- (2020) Catrin Sohrabi et al. Nature Reviews Chemistry
- A review of antibody-based therapeutics targeting G protein-coupled receptors: an update
- (2020) Catherine J. Hutchings EXPERT OPINION ON BIOLOGICAL THERAPY
- Structure and selectivity engineering of the M1 muscarinic receptor toxin complex
- (2020) Shoji Maeda et al. SCIENCE
- Ultra-large chemical libraries for the discovery of high-affinity peptide binders
- (2020) Anthony J. Quartararo et al. Nature Communications
- α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia
- (2020) Adam C. Kennedy et al. Toxins
- PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization
- (2020) Athan Kuliopulos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The PAR4-derived pepducin P4Pal10 lacks effect on neutrophil GPCRs that couple to Gαq for signaling but distinctly modulates function of the Gαi-coupled FPR2 and FFAR2
- (2020) André Holdfeldt et al. BIOCHEMICAL PHARMACOLOGY
- A 5-mer peptide derived from hinge region of hFSHR can function as positive allosteric modulator in vivo
- (2020) Kaushiki S. Prabhudesai et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Design and synthesis of β-strand-fixed peptides inhibiting aggregation of amyloid β-protein
- (2020) Fumiya Tanaka et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Autoantibodies as Endogenous Modulators of GPCR Signaling
- (2020) Meredith A. Skiba et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Hemopressin as a breakthrough for the cannabinoid field
- (2020) Andrea S. Heimann et al. NEUROPHARMACOLOGY
- Multicomponent Reaction Toolbox for Peptide Macrocyclization and Stapling
- (2019) Leslie Reguera et al. CHEMICAL REVIEWS
- Nanobodies detecting and modulating GPCRs outside in and inside out
- (2019) Raimond Heukers et al. CURRENT OPINION IN CELL BIOLOGY
- Paired Utility of Aza-Amino Acyl Proline and Indolizidinone Amino Acid Residues for Peptide Mimicry: Conception of Prostaglandin F2α Receptor Allosteric Modulators That Delay Preterm Birth
- (2019) Fatemeh M. Mir et al. JOURNAL OF MEDICINAL CHEMISTRY
- GPCR interaction as a possible way for allosteric control between receptors
- (2019) Jean-Philippe Pin et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery
- (2019) Edin Muratspahić et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids
- (2019) Keith M. Olson et al. PLoS One
- Mechanism of β2AR regulation by an intracellular positive allosteric modulator
- (2019) Xiangyu Liu et al. SCIENCE
- VEGAS as a Platform for Facile Directed Evolution in Mammalian Cells
- (2019) Justin G. English et al. CELL
- Modulators of CXCR4 and CXCR7/ACKR3 function
- (2019) Ilze Adlere et al. MOLECULAR PHARMACOLOGY
- Conotoxins: Chemistry and Biology
- (2019) Ai-Hua Jin et al. CHEMICAL REVIEWS
- Unraveling allosteric landscapes of allosterome with ASD
- (2019) Xinyi Liu et al. NUCLEIC ACIDS RESEARCH
- Positive Modulation of Angiotensin II Type 1 Receptor–Mediated Signaling by LVV–Hemorphin-7
- (2019) Amanat Ali et al. Frontiers in Pharmacology
- Receptor component protein, an endogenous allosteric modulator of family B G protein coupled receptors
- (2019) Sarah J. Routledge et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Evolving a Peptide: Library Platforms and Diversification Strategies
- (2019) Krištof Bozovičar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Development of “Plug and Play” Fiducial Marks for Structural Studies of GPCR Signaling Complexes by Single-Particle Cryo-EM
- (2019) Przemyslaw Dutka et al. STRUCTURE
- Structure–Activity Studies Reveal the Molecular Basis for GABAB-Receptor Mediated Inhibition of High Voltage-Activated Calcium Channels by α-Conotoxin Vc1.1
- (2018) Mahsa Sadeghi et al. ACS Chemical Biology
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug–Target Interactions
- (2018) Shaoyong Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer that Reduces Morphine Withdrawal in Mice
- (2018) Keith M. Olson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator
- (2018) Yoshiyuki Meguro et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?
- (2018) Krishna Sriram et al. MOLECULAR PHARMACOLOGY
- Small-Molecule Positive Allosteric Modulators of theβ2-Adrenoceptor Isolated from DNA-Encoded Libraries
- (2018) Seungkirl Ahn et al. MOLECULAR PHARMACOLOGY
- Gs protein peptidomimetics as allosteric modulators of the β2-adrenergic receptor
- (2018) Lotte-Emilie Boyhus et al. RSC Advances
- Measuring ligand efficacy at the mu-opioid receptor using a conformational biosensor
- (2018) Kathryn E Livingston et al. eLife
- Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
- (2018) Eric A. Wold et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of an antibody fragment that stabilizes GPCR/G-protein complexes
- (2018) Shoji Maeda et al. Nature Communications
- Pepducin-mediated cardioprotection via β-arrestin-biased β2-adrenergic receptor-specific signaling
- (2018) Laurel A. Grisanti et al. Theranostics
- Targeting of N-Type Calcium Channels via GABAB-Receptor Activation by α-Conotoxin Vc1.1 Variants Displaying Improved Analgesic Activity
- (2018) Fengtao Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crosstalk between receptor tyrosine kinases (RTKs) and G protein-coupled receptors (GPCR) in the brain: Focus on heteroreceptor complexes and related functional neurotrophic effects
- (2018) Valentina Di Liberto et al. NEUROPHARMACOLOGY
- Signaling mechanisms and physiological functions of G-protein Gα13 in blood vessel formation, bone homeostasis, and cancer
- (2018) Viktoriya Syrovatkina et al. PROTEIN SCIENCE
- The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of Schizophrenia
- (2018) Ritesh P. Daya et al. Frontiers in Behavioral Neuroscience
- Enhancing the therapeutic potential of peptide toxins
- (2017) Raymond S. Norton Expert Opinion on Drug Discovery
- Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics
- (2017) Antoine Douchez et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Current State of Peptide Drug Discovery: Back to the Future?
- (2017) Antoine Henninot et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanism of intracellular allosteric β2AR antagonist revealed by X-ray crystal structure
- (2017) Xiangyu Liu et al. NATURE
- Analgesic conopeptides targeting G protein-coupled receptors reduce excitability of sensory neurons
- (2017) Mahsa Sadeghi et al. NEUROPHARMACOLOGY
- Allosteric “beta-blocker” isolated from a DNA-encoded small molecule library
- (2017) Seungkirl Ahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides
- (2017) James Daniel et al. Toxins
- Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage
- (2017) Vanessa Petrucci et al. Scientific Reports
- Structure-Activity Studies of Cysteine-Rich α-Conotoxins that Inhibit High-Voltage-Activated Calcium Channels via GABAB Receptor Activation Reveal a Minimal Functional Motif
- (2016) Bodil B. Carstens et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors
- (2016) Craig W. Lindsley et al. CHEMICAL REVIEWS
- Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation
- (2016) Dean P. Staus et al. NATURE
- Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides
- (2016) Shayli Varasteh Moradi et al. Chemical Science
- An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology
- (2016) Joseph J Gingell et al. Cell Discovery
- Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease
- (2015) Paul A. Gurbel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics
- (2015) Ping Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- De Novo Conception of Small Molecule Modulators Based on Endogenous Peptide Ligands: Pyrrolodiazepin-2-one γ-Turn Mimics That Differentially Modulate Urotensin II Receptor-Mediated Vasoconstriction ex Vivo
- (2015) Julien Dufour-Gallant et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain
- (2015) Aswini Kumar Giri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Universal allosteric mechanism for Gα activation by GPCRs
- (2015) Tilman Flock et al. NATURE
- Structural insights into µ-opioid receptor activation
- (2015) Weijiao Huang et al. NATURE
- Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model
- (2015) Alex Straiker et al. PHARMACOLOGICAL RESEARCH
- Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices
- (2015) Elizaveta S. Leshchiner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1
- (2015) Rilei Yu et al. Scientific Reports
- Automated solid-phase peptide synthesis to obtain therapeutic peptides
- (2014) Veronika Mäde et al. Beilstein Journal of Organic Chemistry
- The design and implementation of a generic lipopeptide scanning platform to enable the identification of ‘locally acting’ agonists for the apelin receptor
- (2014) Stephen C. McKeown et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications
- (2014) N T Burford et al. BRITISH JOURNAL OF PHARMACOLOGY
- Development and Characterization of Pepducins as Gs-biased Allosteric Agonists
- (2014) Richard Carr et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of peptidomimetic ligands of Pro-Leu-Gly-NH2as allosteric modulators of the dopamine D2receptor
- (2013) Swapna Bhagwanth et al. Beilstein Journal of Organic Chemistry
- Mechanisms of conotoxin inhibition of N-type (Cav2.2) calcium channels
- (2013) David J. Adams et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- On the G-Protein-Coupled Receptor Heteromers and Their Allosteric Receptor-Receptor Interactions in the Central Nervous System: Focus on Their Role in Pain Modulation
- (2013) Dasiel O. Borroto-Escuela et al. Evidence-based Complementary and Alternative Medicine
- Peptide Inhibitors Disrupt the Serotonin 5-HT2C Receptor Interaction with Phosphatase and Tensin Homolog to Allosterically Modulate Cellular Signaling and Behavior
- (2013) N. C. Anastasio et al. JOURNAL OF NEUROSCIENCE
- Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens
- (2013) N Kabli et al. MOLECULAR PSYCHIATRY
- Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide
- (2013) Arun K. Shukla et al. NATURE
- Signalling bias in new drug discovery: detection, quantification and therapeutic impact
- (2013) Terry Kenakin et al. NATURE REVIEWS DRUG DISCOVERY
- Emerging paradigms in GPCR allostery: implications for drug discovery
- (2013) Denise Wootten et al. NATURE REVIEWS DRUG DISCOVERY
- FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes
- (2013) Mieko Tsuji et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy
- (2013) Yong S. Chang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein
- (2013) J. Quoyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Restoration of renal function by a novel prostaglandin EP4 receptor-derived peptide in models of acute renal failure
- (2012) Martin Leduc et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation
- (2012) D Chatenet et al. BRITISH JOURNAL OF PHARMACOLOGY
- Peptide Scanning for Studying Structure-Activity Relationships in Drug Discovery
- (2012) Andrew G. Jamieson et al. Chemical Biology & Drug Design
- Suppression of Arterial Thrombosis Without Affecting Hemostatic Parameters With a Cell-Penetrating PAR1 Pepducin
- (2012) Ping Zhang et al. CIRCULATION
- PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia
- (2012) Michael G.R. Beyaert et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Conopeptide ρ-TIA Defines a New Allosteric Site on the Extracellular Surface of the α1B-Adrenoceptor
- (2012) Lotten Ragnarsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The differential extraction and immunoluminometric assay of Urotensin II and Urotensin-related peptide in heart failure
- (2012) P.P. Jani et al. PEPTIDES
- Engineering of Three-Finger Fold Toxins Creates Ligands with Original Pharmacological Profiles for Muscarinic and Adrenergic Receptors
- (2012) Carole Fruchart-Gaillard et al. PLoS One
- Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer
- (2011) Jaroslaw Cisowski et al. AMERICAN JOURNAL OF PATHOLOGY
- Urocontrin, a novel UT receptor ligand with a unique pharmacological profile
- (2011) David Chatenet et al. BIOCHEMICAL PHARMACOLOGY
- Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia
- (2011) K. O'Callaghan et al. BLOOD
- Structural Model of Ligand-G Protein-coupled Receptor (GPCR) Complex Based on Experimental Double Mutant Cycle Data
- (2011) Catherine Marquer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the Prostaglandin F2α Receptor for Preventing Preterm Labor with Azapeptide Tocolytics
- (2011) Carine B. Bourguet et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Validation of a β-Turn Mimetic Library Targeting Protein–Protein and Peptide–Receptor Interactions
- (2011) Landon R. Whitby et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Direct Interaction between an Allosteric Agonist Pepducin and the Chemokine Receptor CXCR4
- (2011) Jay M. Janz et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Crystal structure of the β2 adrenergic receptor–Gs protein complex
- (2011) Søren G. F. Rasmussen et al. NATURE
- Contemporary strategies for peptide macrocyclization
- (2011) Christopher J. White et al. Nature Chemistry
- Facilitation of μ-Opioid Receptor Activity by Preventing δ-Opioid Receptor-Mediated Codegradation
- (2011) Shao-Qiu He et al. NEURON
- Muscarinic toxins
- (2011) Denis Servent et al. TOXICON
- The Engineering of an Orally Active Conotoxin for the Treatment of Neuropathic Pain
- (2010) Richard J. Clark et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Strategies for the identification of allosteric modulators of G-protein-coupled receptors
- (2010) Neil T. Burford et al. BIOCHEMICAL PHARMACOLOGY
- Mapping the Druggable Allosteric Space of G-Protein Coupled Receptors: a Fragment-Based Molecular Dynamics Approach
- (2010) Anthony Ivetac et al. Chemical Biology & Drug Design
- Ligand-Based Peptide Design and Combinatorial Peptide Libraries to Target G Protein-Coupled Receptors
- (2010) Christian W. Gruber et al. CURRENT PHARMACEUTICAL DESIGN
- A Novel Biased Allosteric Compound Inhibitor of Parturition Selectively Impedes the Prostaglandin F2α-mediated Rho/ROCK Signaling Pathway
- (2010) Eugénie Goupil et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells
- (2010) B. Tchernychev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: Implications for the treatment of negative symptoms in schizophrenia
- (2010) Bailee Dyck et al. SCHIZOPHRENIA RESEARCH
- VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist
- (2009) L. Rihakova et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site
- (2009) Vishal Trivedi et al. CELL
- Allosteric Modulation of the Dopamine D2Receptor by Pro-Leu-Gly-NH2Peptidomimetics Constrained in Either a Polyproline II Helix or a Type II β-Turn Conformation
- (2009) Bhooma Raghavan et al. JOURNAL OF MEDICINAL CHEMISTRY
- β-Hairpin Peptidomimetics: Design, Structures and Biological Activities
- (2008) John A. Robinson ACCOUNTS OF CHEMICAL RESEARCH
- Peptidomimetics, a synthetic tool of drug discovery
- (2008) Josef Vagner et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Analgesic -Conotoxins Vc1.1 and Rg1A Inhibit N-Type Calcium Channels in Rat Sensory Neurons via GABAB Receptor Activation
- (2008) B. Callaghan et al. JOURNAL OF NEUROSCIENCE
- Synthesis and evaluation of novel pyridine based PLG tripeptidomimetics
- (2008) Stina Saitton et al. ORGANIC & BIOMOLECULAR CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now